In 2022, Hanmi Pharmaceutical Co., Ltd. and its subsidiaries' R&D investment amounted to a total of around 178 billion South Korean won. This represents an increase from the previous year.
Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Sales revenue Celltrion 2013-2022
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
About the region
10
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2023
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
Selected statistics
10
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
Other regions
10
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Premium Statistic Main pharmacies in Mexico 2019, by size
- Premium Statistic Value added of pharmaceutical companies in Italy 2016-2018
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Basic Statistic Gross profit of Sobi 2009-2023
- Premium Statistic Chemicals and pharma consumption in Russia 2021, by segment
- Premium Statistic Colombia: pharmaceutical establishments 2014-2018
Related statistics
9
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
- Premium Statistic Yuhan-Kimberly's net profit 2016-2019
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Sales revenue distribution Yuhan 2022, by sector
- Premium Statistic Yuhan-Kimberly's sales revenue 2016-2019
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Value of chemical exports: North America 2005-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Global revenue of the chemical industry 2017-2022, by region
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Value of chemical exports: North America 2005-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Global revenue of the chemical industry 2017-2022, by region
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
Hanmi Pharmaceutical. (July 18, 2023). Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)* [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. "Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)*." Chart. July 18, 2023. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. (2023). Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)*. Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. "Consolidated Investment in Research and Development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in Billion South Korean Won)*." Statista, Statista Inc., 18 Jul 2023, https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical, Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)* Statista, https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/ (last visited May 13, 2024)
Consolidated investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)* [Graph], Hanmi Pharmaceutical, July 18, 2023. [Online]. Available: https://www.statista.com/statistics/964546/hanmi-pharmaceutical-r-d-investment/